EG 427 is a biotechnology company leading the development of pinpoint DNA medicine solutions. It has developed a non-replicative Herpes Simplex Virus type 1 (nrHSV-1) based vector platform which delivers, with pinpoint precision, highly selective, durable expression of disease-modifying transgenes. The company leverages the technology to design new treatments for peripheral nervous system disorders and …